14-day Premium Trial Subscription Try For FreeTry Free
$0.0008
+0 (+0%)
At Close: May 03, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions Profile

Range Low Price High Price Comment
30 days $0.0007 $0.0023 Friday, 3rd May 2024 PPCB stock ended at $0.0008. During the day the stock fluctuated 14.29% from a day low at $0.0007 to a day high of $0.0008.
90 days $0.0007 $0.0065
52 weeks $0.0001 $0.263

Historical Propanc Biopharma Inc prices

Date Open High Low Close Volume
Mar 11, 2016 $0.0361 $0.0516 $0.0355 $0.0488 41 062 722
Mar 10, 2016 $0.0264 $0.0370 $0.0225 $0.0355 26 915 587
Mar 09, 2016 $0.0245 $0.0284 $0.0238 $0.0254 10 548 737
Mar 08, 2016 $0.0200 $0.0260 $0.0188 $0.0230 23 908 274
Mar 07, 2016 $0.0129 $0.0221 $0.0125 $0.0188 23 829 239
Mar 04, 2016 $0.0114 $0.0129 $0.0108 $0.0129 10 674 186
Mar 03, 2016 $0.0115 $0.0120 $0.0106 $0.0113 14 190 509
Mar 02, 2016 $0.0108 $0.0170 $0.0107 $0.0119 45 636 904
Mar 01, 2016 $0.0110 $0.0110 $0.0100 $0.0105 8 040 437
Feb 29, 2016 $0.0104 $0.0109 $0.0103 $0.0107 3 249 822
Feb 26, 2016 $0.0119 $0.0119 $0.0101 $0.0104 12 996 724
Feb 25, 2016 $0.0120 $0.0124 $0.0108 $0.0119 7 381 305
Feb 24, 2016 $0.0140 $0.0140 $0.0101 $0.0110 19 517 050
Feb 23, 2016 $0.0158 $0.0158 $0.0140 $0.0140 11 143 132
Feb 22, 2016 $0.0161 $0.0175 $0.0150 $0.0151 5 335 145
Feb 19, 2016 $0.0154 $0.0168 $0.0148 $0.0164 3 976 252
Feb 18, 2016 $0.0157 $0.0157 $0.0148 $0.0151 2 606 438
Feb 17, 2016 $0.0150 $0.0160 $0.0148 $0.0157 2 724 252
Feb 16, 2016 $0.0160 $0.0160 $0.0145 $0.0145 4 720 799
Feb 12, 2016 $0.0155 $0.0160 $0.0140 $0.0160 12 037 369
Feb 11, 2016 $0.0160 $0.0160 $0.0153 $0.0157 3 381 394
Feb 10, 2016 $0.0164 $0.0173 $0.0155 $0.0160 3 549 592
Feb 09, 2016 $0.0180 $0.0180 $0.0155 $0.0160 6 205 914
Feb 08, 2016 $0.0203 $0.0210 $0.0170 $0.0170 3 815 201
Feb 05, 2016 $0.0215 $0.0226 $0.0195 $0.0196 3 933 796
Click to get the best stock tips daily for free!

About Propanc Biopharma Inc

Propanc Biopharma Propanc Biopharma, Inc., a biopharmaceutical company, focuses on the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Its lead product is PRP, a formulation that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes acting synergistically. The company has a research collaboration with University of Jaén to commence the POP1 joint drug disc... PPCB Profile

Golden Star

Ticker Date Change Price
BSCQ Apr 30 0.393% $19.09
EQC Apr 30 1.76% $18.72
HRB Apr 30 1.69% $47.23
REG Apr 30 1.35% $59.22
INGR Apr 30 0.576% $114.59
BSJP Apr 29 0.175% $22.91
LYG Apr 29 0.781% $2.56
ORA Apr 29 3.46% $64.48
DHT Apr 24 4.34% $11.28
LPLA Apr 19 2.62% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT